Sign Up Today and Learn More About Health Data Analytics Institute Stock
Invest in or calculate the value of your shares in Health Data Analytics Institute or other pre-IPO companies through EquityZen's platform.
Health Data Analytics Institute Stock (HDAI)
HDAI is an health care analytics company with a platform that creates a shared understanding of health risks and personalized care profiles.
About Health Data Analytics Institute Stock
Founded
2016
Headquarters
Dedham, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Health Data Analytics Institute Press Mentions
Stay in the know about the latest news on Health Data Analytics Institute
Follow-Up Visits Can Significantly Reduce Post-Discharge Mortality and Readmissions for Highest Risk Patients
prnewswire • Oct 31, 2024
Health Data Analytics Institute (HDAI) on LinkedIn: World's Best Digital Health Companies 2024 - Data Analytics
linkedin • May 23, 2024
HIStalk on LinkedIn: Welcome! You are invited to join a webinar: Houston Methodist: Deploying…
linkedin • Apr 08, 2024
HDAI to Present at ViVE 2024 on How Clinicians Can Put AI to Work
prnewswire • Apr 08, 2024
Health Data Analytics Institute (HDAI) on LinkedIn: #ai #healthcareai #healthcare #innovationinhealthcare ...
linkedin • Apr 08, 2024
Health Data Analytics Institute Management
Leadership team at Health Data Analytics Institute
VP Customer Engagement
Carola Endicott
EVP & COO
Phil Devlin
Join now and verify your accreditation status to gain access to:
- Health Data Analytics Institute current valuation
- Health Data Analytics Institute stock price
- Available deals in Health Data Analytics Institute and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Health Data Analytics Institute Stock
How to invest in Health Data Analytics Institute stock?
Accredited investors can buy pre-IPO stock in companies like Health Data Analytics Institute through EquityZen funds. These investments are made available by existing Health Data Analytics Institute shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Health Data Analytics Institute stock?
Shareholders can sell their Health Data Analytics Institute stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."